NCT00846235
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Orion Pharma R&D Espoo, Finland
Clinical trial condition
Dermatitis, Atopic
Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.
152 public trials
8 recruiting studies
Dermatitis, Atopic trial results
NCT00837551
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Innovaderm Research Inc., Montreal, Quebec, Canada
Completed
Efalizumab for Eczema
NCT00146003
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- UMDNJ Psoriasis Center of Excellence New Brunswick, New Jersey, United States
NCT00267826
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- University of Bern, Department of Dermatology Bern, Switzerland
NCT00121381
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Pediatric Care Medical Group, Inc. Huntington Beach, California, United States
- Children's Hospital -San Diego San Diego, California, United States
- National Jewish Medical and Research Center Denver, Colorado, United States
- Dermatology Associates and Research Coral Gables, Florida, United States
Active, Not Recruiting
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
NCT06353087
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +10 more
- Locations
-
- Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
- Chang Gung Memorial Hospital at Kaohsiung Kaohsiung City, Taiwan
- Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan
- NTUH Taipei, Taiwan
Active, Not Recruiting
Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)
NCT07582237
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Bucheon Hospital, Soonchunhyang University Bucheon-si, South Korea
Active, Not Recruiting
A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
NCT06526182
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Hospital General Universitario Dr. Balmis Alicante, Spain
- Hospital del Mar - Parc de Salut Mar Barcelona, Spain
- Hospital Universitario Clínico San Cecilio Granada, Spain
- Consorci Hospital General Universitari de València Valencia, Spain
Active, Not Recruiting
Evaluate the Safety, Tolerability of BAT6026
NCT06094179
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
- Locations
-
- Jianzhong Zhang Beijing, Beijing Municipality, China
Active, Not Recruiting
Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
NCT03428646
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Regeneron Investigational Site Birmingham, Alabama, United States
- Regeneron Investigational Site Gilbert, Arizona, United States
- Regeneron Investigational Site Fountain Valley, California, United States
- Regeneron Investigational Site Laguna Hills, California, United States